Tadao Orii
Papers
2
Total Citations
60
H-Index
2
About
Dr. Tadao Orii is a leading figure in the diagnosis and management of lysosomal storage disorders, with a particular focus on mucopolysaccharidoses (MPS). His research has fundamentally advanced newborn screening and biochemical diagnostics, aiming to improve early detection and treatment outcomes for these devastating genetic diseases. Dr. Orii’s major contributions include pioneering the application of tandem mass spectrometry for high-throughput, automated analysis of heparan sulfate and other glycosaminoglycans (GAGs)—the key biomarkers for MPS. His seminal 2014 work, cited 36 times, introduced a novel, rapid assay that dramatically improved the sensitivity and efficiency of MPS screening, moving beyond traditional, slower methods. This work, alongside his 2014 study on newborn screening (24 citations), has established a new standard for early diagnosis, enabling timely intervention before irreversible damage occurs. By translating complex biochemistry into practical, scalable clinical tools, Dr. Orii has directly impacted the lives of countless patients and families, providing a critical foundation for future therapeutic monitoring and precision medicine in inherited metabolic disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2